1
/
of
0
FDA: FDA Correspondence on EzriCare Artificial Tears Contamination
FDA: FDA Correspondence on EzriCare Artificial Tears Contamination
Regular price
$89.00 USD
Regular price
Sale price
$89.00 USD
Unit price
/
per
Request Content: Correspondence between FDA staff and representatives of Global Pharma Healthcare, EzriCare, or Delsam Pharma regarding the issues raised in FDA’s warning about EzriCare Artificial Tears contamination.
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details